The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.
The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Source: http://marchmontnews.com/Finance-Business/Central-regions/21600-HIV-drug-development-under-way-gets-...